Rundu Pharma: Net loss of 36.1931 million yuan in the first half of 2025
Rundu Pharma announced that its operating revenue in the first half of 2025 was 548 million yuan, a year-on-year decrease of 8.22%. The net profit attributable to shareholders of the listed company was -36.1931 million yuan, a year-on-year decrease of 195.75%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to increase capital through reserves
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments